LANEIGE SunScreen Triple description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

LANEIGE SunScreen Triple

AMOREPACIFIC

LANEIGE SunScreen Triple


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

ACTIVE INGREDIENTS

ETHYLHEXYL METHOXYCINNAMATE 7%
TITANIUM DIOXIDE 5.81%
ZINC OXIDE 1.96%

PURPOSE

Sunscreen

USE

  • helps prevent sunburn

WARNINGS

Skin Cancer/Skin Aging Alert

Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to prevent sunburn, not skin cancer or early skin aging.

  • For external use only
  • Do not use on damaged or broken skin
  • When using this product keep out of eyes. Rinse with water to remove.
  • Stop use and ask a doctor if rash occurs
  • Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

  • apply liberally 15 minutes before sun exposure
  • reapply at least every 2 hours
  • use a water-resistant sunscreen if swimming or sweating
  • children under 6 months of age: Ask a doctor

INACTIVE INGREDIENTS

WATER, CYCLOPENTASILOXANE, CYCLOHEXASILOXANE, BUTYLENE GLYCOL, DICAPRYLYL CARBONATE, LAURYL PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE, SORBITAN ISOSTEARATE, DISTEARDIMONIUM HECTORITE, VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER, SODIUM CHLORIDE, DIMETHICONE/PEG-10/15 CROSSPOLYMER, ALUMINUM HYDROXIDE, ACRYLATES/ETHYLHEXYL ACRYLATE/DIMETHICONE METHACRYLATE COPOLYMER, STEARIC ACID, OZOKERITE, CAPRYLYL GLYCOL, SODIUM CITRATE, ETHYLHEXYLGLYCERIN, DISODIUM EDTA, TRIETHOXYCAPRYLYLSILANE, ADENOSINE, MAGNESIUM SULFATE, MANGANESE SULFATE, ZINC SULFATE, FRAGRANCE, TITANIUM DIOXIDE (CI 77891), MICA (CI 77019)

OTHER INFORMATION

  • protect the product in this container from excessive heat and direct sun

PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton

LANEIGE

SunScreen
Triple

Sunscreen
SPF 40

50 mL / 1.6 FL.OZ. e

LANEIGE SunScreen Triple

LANEIGE SunScreen Triple

OCTINOXATE, TITANIUM DIOXIDE, and ZINC OXIDE CREAM

Product Information

Product Type Human otc drug label Item Code (Source) NDC:43419-811
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 70 mg
titanium dioxide 58.1 mg
Zinc Oxide Zinc oxide 19.6 g

Inactive Ingredients

Ingredient Name Strength
water
CYCLOMETHICONE 5
CYCLOMETHICONE 6
BUTYLENE GLYCOL
DICAPRYLYL CARBONATE
LAURYL PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE
Sorbitan Isostearate
DISTEARDIMONIUM HECTORITE
SODIUM CHLORIDE
aluminum hydroxide
STEARIC ACID
CAPRYLYL GLYCOL
SODIUM CITRATE
ETHYLHEXYLGLYCERIN
EDETATE DISODIUM
TRIETHOXYCAPRYLYLSILANE
ADENOSINE
MAGNESIUM SULFATE
MANGANESE SULFATE
ZINC SULFATE
MICA

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 50 in 1 TUBE
2 NDC:43419-811-83 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2013-07-05


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.